|Radiation dose–volume effects in the brain|
YR Lawrence, XA Li, I El Naqa, CA Hahn, LB Marks, TE Merchant, ...
International Journal of Radiation Oncology* Biology* Physics 76 (3), S20-S27, 2010
|Patient-oriented cancer information on the internet: a comparison of wikipedia and a professionally maintained database|
MS Rajagopalan, VK Khanna, Y Leiter, M Stott, TN Showalter, AP Dicker, ...
Journal of Oncology Practice 7 (5), 319-323, 2011
|Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?|
YR Lawrence, DT Blumenthal, D Matceyevsky, AA Kanner, F Bokstein, ...
Journal of neuro-oncology 105, 1-7, 2011
|Cancer of unknown primary: a population-based analysis of temporal change and socioeconomic disparities|
D Urban, A Rao, M Bressel, YR Lawrence, L Mileshkin
British journal of cancer 109 (5), 1318-1324, 2013
|Splenic infarction: an update on William Osler's observations.|
MA Lawrence, YR MBBS MRCP, MB Pokroy, MB Berlowitz, MD Aharoni, ...
|Quality assurance peer review chart rounds in 2011: A survey of academic institutions in the United States|
YR Lawrence, MA Whiton, Z Symon, EJ Wuthrick, L Doyle, AS Harrison, ...
International Journal of Radiation Oncology* Biology* Physics 84 (3), 590-595, 2012
|NCI–RTOG translational program strategic guidelines for the early-stage development of radiosensitizers|
YR Lawrence, B Vikram, JJ Dignam, A Chakravarti, M Machtay, B Freidlin, ...
Journal of the National Cancer Institute 105 (1), 11-24, 2013
|Improving prognosis of glioblastoma in the 21st century: who has benefited most?|
YR Lawrence, MV Mishra, M Werner‐Wasik, DW Andrews, TN Showalter, ...
Cancer 118 (17), 4228-4234, 2012
|Changing prognosis of metastatic colorectal adenocarcinoma: Differential improvement by age and tumor location|
T Golan, D Urban, R Berger, YR Lawrence
Cancer 119 (16), 3084-3091, 2013
|Does choline PET/CT change the management of prostate cancer patients with biochemical failure?|
J Goldstein, E Even-Sapir, S Ben-Haim, A Saad, B Spieler, T Davidson, ...
American Journal of Clinical Oncology 40 (3), 256-259, 2017
|Short-and long-term survival in metastatic pancreatic adenocarcinoma, 1993–2013|
T Golan, T Sella, O Margalit, U Amit, N Halpern, D Aderka, ...
Journal of the National Comprehensive Cancer Network 15 (8), 1022-1027, 2017
|Eukaryotic Initiation Factor 2α-a Downstream Effector of Mammalian Target of Rapamycin-Modulates DNA Repair and Cancer Response to Treatment|
L Tuval-Kochen, S Paglin, G Keshet, Y Lerenthal, C Nakar, T Golani, ...
PloS one 8 (10), e77260, 2013
|Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas|
W Shi, JD Palmer, M Werner-Wasik, DW Andrews, JJ Evans, J Glass, ...
Journal of neuro-oncology 127, 535-539, 2016
|Characterization and outcomes of optic nerve gliomas: a population-based analysis|
MV Mishra, DW Andrews, J Glass, JJ Evans, AP Dicker, X Shen, ...
Journal of neuro-oncology 107, 591-597, 2012
|mTOR is a selective effector of the radiation therapy response in androgen receptor-positive prostate cancer|
MJ Schiewer, R Den, DT Hoang, MA Augello, YR Lawrence, AP Dicker, ...
Endocrine-related cancer 19 (1), 1, 2012
|Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial|
W Shi, YR Lawrence, H Choy, M Werner-Wasik, DW Andrews, JJ Evans, ...
Journal of neuro-oncology 118, 313-319, 2014
|Predictors of radiation oncology resident research productivity|
JM Gutovich, RB Den, M Werner-Wasik, AP Dicker, YR Lawrence
Journal of the American College of Radiology 10 (3), 185-189, 2013
|A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas|
RB Den, M Kamrava, Z Sheng, M Werner-Wasik, E Dougherty, ...
International Journal of Radiation Oncology* Biology* Physics 85 (2), 321-328, 2013
|Extreme leukocytosis in the emergency department|
YR Lawrence, D Raveh, B Rudensky, G Munter
Journal of the Association of Physicians 100 (4), 217-223, 2007
|Lymph node ratio predicts the benefit of post-operative radiotherapy in oral cavity cancer|
D Urban, I Gluck, MR Pfeffer, Z Symon, YR Lawrence
Radiotherapy and Oncology 106 (1), 74-79, 2013